Provenienza dei contatti di primo grado di Heinrich Hornef
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Heinrich Hornef tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| DNAPRINT GENOMICS, INC. | Biotechnology | Chief Executive Officer | |
Windgap Medical, Inc.
 Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Windgap Medical, Inc. engages in the development of epinephrine autoinjector for the treatment of anaphylaxis. The company was founded was founded by Christopher J. Stepanian and Brent Buchine and is headquartered in Somerville, MA. | Pharmaceuticals: Major | Director/Board Member | |
Semaphore, Inc.
 Semaphore, Inc. Packaged SoftwareTechnology Services Part of Roper Technologies, Inc., Semaphore, Inc. develops and distributes advanced financial and project management software. The company is based in New York, NY. The company was founded by Omid C. Farokhzad. Semaphore was acquired by Deltek Systems, Inc. on August 10, 2000 for $10 million. | Packaged Software | Corporate Officer/Principal | |
| Suffolk University | College/University | Masters Business Admin | |
| Ohio Dominican University | College/University | Undergraduate Degree | |
| CALIX, INC. | Telecommunications Equipment | Chief Executive Officer | |
Trace Genetics, Inc.
 Trace Genetics, Inc. BiotechnologyHealth Technology Part of DNAPrint Genomics, Inc., Trace Genetics, Inc. provides products and services for the genealogy, forensics, and molecular diagnostics markets. The company is based in Richmond, CA. Trace Genetics was acquired by DNAPrint Genomics, Inc. on June 21, 2005 for $0.38 million. | Biotechnology | Director/Board Member | |
Ellipsis Biotherapeutics Corp.
 Ellipsis Biotherapeutics Corp. Miscellaneous Commercial ServicesCommercial Services Part of DNAPrint Genomics, Inc., Ellipsis Biotherapeutics Corp. provides commercial genotyping services and gene research. The company is based in Toronto, Canada. Ellipsis Biotherapeutics was acquired by DNAPrint Genomics, Inc. on December 19, 2005 for $0.11 million. | Miscellaneous Commercial Services | Director/Board Member | |
| MediVector, Inc. | Corporate Officer/Principal | ||
| PREDICTIVE ONCOLOGY INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| GLG PHARMA S.A. | Pharmaceuticals: Major | Chief Operating Officer | |
Dnaprint Pharmaceuticals, Inc.
 Dnaprint Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Dnaprint Pharmaceuticals, Inc. develops theranostic genetic drug combinations. The private company is based in Sarasota, FL. | Miscellaneous Commercial Services | Chief Executive Officer | |
GLG Pharma LLC
 GLG Pharma LLC BiotechnologyHealth Technology GLG Pharma LLC operates as a biotechnology company. It develops personalized therapies for patients with cancer and other proliferative diseases. The company was founded by Hector J. Gomez, Richard H. Gabriel and Tony Frudakis in 2009 and is headquartered in Jupiter, FL. | Biotechnology | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 12 |
| Canada | 2 |
| Polonia | 2 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 3 |
| Technology Services | 2 |
| Electronic Technology | 2 |
Posizioni
| Director/Board Member | 5 |
| Chief Executive Officer | 4 |
| President | 3 |
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
Contatti più connessi
| Insiders | |
|---|---|
| Richard L. Gabriel | 14 |
- Borsa valori
- Insiders
- Heinrich Hornef
- Connessioni Società
